Hemispherx Biopharma, Inc. Employee Directory
Pharmaceutical ManufacturingFlorida, United States11-50 Employees
Hemispherx Biopharma, based in Ocala, Florida, is a small to midsize specialty pharmaceutical company focused on the clinical development of new drug entities for seriously debilitating disorders. Its flagship products include Alferon N Injection and Ampligen; Ampligen is an experimental RNA-based therapeutic being developed for immune-related diseases, including Chronic Fatigue Syndrome, and is available only through clinical trials. Alferon N Injection has FDA approval limited to treating refractory or recurrent external genital warts in adults, while Argentina grants approval under the Naturaferon brand for patients who fail or are intolerant to recombinant interferon, including those with chronic active hepatitis C. The company operates a GMP-certified manufacturing facility in the United States for commercial products. Hemispherx's focus centers on immunology and severely debilitating conditions, leveraging its platform technology to support development in this area. In 2020, the company indicated efforts to establish clinical trials for COVID-19 as both a protective prophylaxis and an early-onset treatment.